Skip to main content

Davern Capital Partners, LP

SEC CIK
0002003147
Latest filing
Aug 13, 2026

ROIV holding history

Roivant Sciences Ltd. in every 13F filed by Davern Capital Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ROIV overviewAll 13F holders of ROIVFull Q2 2026 holdings

Shares (Q2 2026)
1,932,904
Value
$68.4M
% of portfolio
11.7%
Quarters held
3
Since Q4 2025
Holdings of ROIV by Davern Capital Partners, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,932,904$68.4M11.7%+1,059,506+121.3%AddedHolders
Q1 2026873,398$24.2M6.6%−154,900−15.1%ReducedHolders
Q4 20251,028,298$22.3M7.2%–No prior filingHolders